00126-9/asset/7eb2e97c-9e0c-4d03-8f7f-38f93e2cc509/main.assets/gr2_lrg.jpg)
cagrilintide tirzepatide combination study Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a Cagrilintide Dosage with Tirzepatide: Dual
Description
Compare that to 100 units at 10mg/ml concentration
Patients should never stop either medication abruptly without medical advice, as this may lead to symptom recurrence
How often should my tirzepatide dose be increased
Victoza is FDA-approved for the treatment of type 2 diabetes, while Saxenda is FDA-approved for the treatment of obesity
Hosaka, M
